-

SHAREHOLDER ALERT: Robbins LLP Announces That Franklin Wireless Corp. (FKWL) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Franklin Wireless Corp. (NASDAQ: FKWL) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between September 17, 2020 and April 8, 2021. Franklin purports to be a leading provider of intelligent wireless solutions such as mobile hotspots, routers, trackers, and other devices.

If you suffered a loss due to Franklin Wireless Corp.'s misconduct, click here.

Franklin Wireless Corp. (FKWL) Failed to Disclose its Hotspot Devices Suffered from Battery Issues

According to the complaint, on April 1, 2021, Franklin stated that it "ha[d] been notified of reports of battery issues in some of its wireless hotspot device" and that it was "working with its battery and device manufacturing partners and carrier customer to determine the cause and extent of the problem." Then, on April 8, media reported that Verizon Wireless "is recalling 2.5 million hotspot devices after discovering that the lithium ion battery can overheat, creating a fire and burning hazard." The "recall impacts Ellipsis Jetpack mobile hotspots imported by Franklin Wireless Corp and sold between April 2017 and March 2021." On this news, the stock price fell 14%, to close at $17.33 per share on April 8. 2021. The next day, Franklin announced that Verizon "has issued a voluntary recall of its Jetpack Hotspot devices imported by Franklin." On this news, Franklin's stock price fell nearly 23%, to close at $13.26 per share on April 9, 2021.

If you purchased shares of Franklin Wireless Corp. (FKWL) between September 17, 2020 and April 8, 2021, you have until June 15, 2021, to ask the court to appoint you lead plaintiff for the class. If you would like more information regarding your rights, please contact Lauren Levi at (800) 350-6003 or llevi@robbinsllp.com, or via our Shareholder Information Form.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Franklin Wireless Corp. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Graphic Packaging Holding Company Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Graphic Packaging Holding Company (NYSE: GPK) common stock between February 4, 2025 and February 2, 2026. Graphic Packaging, together with its subsidiaries, designs, produces, and sells consumer packaging products. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbin...

Babcock & Wilcox Enterprises, Inc. Class Action Reminder - Robbins LLP Encourages BW Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Babcock & Wilcox Enterprises, Inc. (NYSE: BW) securities between November 5, 2025 and March 11, 2026. Babcock & Wilcox provides energy and emissions control solutions to industrial, electrical utility, municipal, and other customers in the U.S., Canada, the U.K., Indonesia, and the Philippines.For more information, submit a form, email...

Investor Notice: Robbins LLP Informs Investors of the Immutep Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune diseases. The company’s product pipeline includes TACTI-004, which is in phase II...
Back to Newsroom